Oxa-Med Oxandrolone Bioniche Pharma


Categories: ,


Oxa-Med Oxandrolone Bioniche Pharma

Introducing Oxa-Med Oxandrolone Bioniche Pharma, a high-quality anabolic steroid designed to enhance performance and promote muscle growth. With its potent formula and exceptional benefits, this product is a must-have for bodybuilders and fitness enthusiasts.

Specific Details and Features

  • Brand: Bioniche Pharma
  • Active Ingredient: Oxandrolone
  • Strength: 10mg per tablet
  • Pack Size: 100 tablets
  • Manufacturer: Bioniche Pharmaceuticals


  • Promotes lean muscle growth
  • Enhances strength and endurance
  • Improves muscle recovery
  • Increases nitrogen retention
  • Boosts protein synthesis

Potential Side Effects

While Oxa-Med Oxandrolone Bioniche Pharma is generally well-tolerated, it is important to be aware of potential side effects, which may include:

  • Acne
  • Hair loss
  • Changes in libido
  • Suppression of natural testosterone production
  • Virilization in women (development of male characteristics)

Uses and Dosage

Oxa-Med Oxandrolone Bioniche Pharma is suitable for both beginners and experienced bodybuilders. The recommended dosage for beginners is 20-40mg per day, while experienced users can take 40-80mg per day. It is important to follow the recommended dosage and consult with a healthcare professional before starting any steroid cycle.

Value for Buyers

By purchasing Oxa-Med Oxandrolone Bioniche Pharma from our steroids-uk-buy.com website in the UK, you can enjoy several benefits:

  • Authentic and high-quality product
  • Discreet packaging and delivery
  • Competitive pricing
  • Secure online payment options
  • Excellent customer service

With its exceptional formula, Oxa-Med Oxandrolone Bioniche Pharma offers bodybuilders and fitness enthusiasts the opportunity to achieve their desired physique and performance goals. Don’t miss out on this top-notch product!


There are no reviews yet.

Be the first to review “Oxa-Med Oxandrolone Bioniche Pharma”

Your email address will not be published. Required fields are marked *